22-41987241-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001363845.2(SEPTIN3):c.1861G>A(p.Val621Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,613,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363845.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN3 | NM_001363845.2 | c.1861G>A | p.Val621Ile | missense_variant | 5/12 | ENST00000644076.2 | NP_001350774.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEPTIN3 | ENST00000644076.2 | c.1861G>A | p.Val621Ile | missense_variant | 5/12 | NM_001363845.2 | ENSP00000494051.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 52AN: 250894Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135604
GnomAD4 exome AF: 0.000120 AC: 175AN: 1461426Hom.: 0 Cov.: 30 AF XY: 0.000138 AC XY: 100AN XY: 727026
GnomAD4 genome AF: 0.000184 AC: 28AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.367G>A (p.V123I) alteration is located in exon 4 (coding exon 4) of the SEPT3 gene. This alteration results from a G to A substitution at nucleotide position 367, causing the valine (V) at amino acid position 123 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at